Literature DB >> 24965339

Efficacy of postoperative radiotherapy for high grade meningiomas.

Yunseon Choi1, Do Hoon Lim, Kyungil Jo, Do-Hyun Nam, Ho Jun Seol, Jung-Il Lee.   

Abstract

The necessity of postoperative radiotherapy (PORT) for meningiomas remains contentious. Here, the role of PORT in patients who underwent surgical resection for WHO grade II and III meningiomas was assessed. The record of 114 patients with WHO grade II (n = 72) and III (n = 42) meningiomas treated at Samsung Medical Center between March 1995 and April 2013 were reviewed and classified according to the extent of surgical resection and implementation of PORT. Median follow-up was 55.9 months. Simpson grade (SG) I, II, III, and IV resections were achieved in 29, 56, 9 and 20 patients, respectively. The 5-year local control (LC) and overall survival rate was 65.8 and 84.2 %, respectively. Thirty patients (26.3 %) developed local failure and five patients (4.4 %) developed distant metastases. The extent of surgical resection (SG I-II vs. III-IV) was influenced by tumor location (orbital and skull base lesions vs. others, p = 0.001) and the surgeons' experience (>10 operations, p = 0.044). Extent of surgical resection was also associated with local failure, overall progression, and overall survival (p = 0.001, p < 0.001, and p < 0.001, respectively). PORT improved LC in patients with incomplete surgical resection (SG III-IV, p = 0.049). Complete resection (SG I-II) is an important prognostic factor for LC and survival, and the extent of surgical resection (SG I-II vs. III-IV) is influenced by tumor location. PORT could improve the LC in WHO grade II-III meningioma patients who underwent incomplete surgical resection (SG III-IV).

Entities:  

Mesh:

Year:  2014        PMID: 24965339     DOI: 10.1007/s11060-014-1507-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

Review 1.  Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?

Authors:  H J Marcus; S J Price; M Wilby; T Santarius; R W Kirollos
Journal:  Br J Neurosurg       Date:  2008-08       Impact factor: 1.596

Review 2.  Meningioma: review of the literature with emphasis on the approach to radiotherapy.

Authors:  Gustavo Nader Marta; Sebastião Francisco Miranda Correa; Manoel Jacobsen Teixeira
Journal:  Expert Rev Anticancer Ther       Date:  2011-11       Impact factor: 4.512

Review 3.  Opportunities for clinical research in meningioma.

Authors:  Michael A Vogelbaum; C Leland Rogers; Mark A Linskey; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-11       Impact factor: 4.130

4.  Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.

Authors:  Soichi Oya; Kensuke Kawai; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Neurosurg       Date:  2012-05-04       Impact factor: 5.115

5.  Meningioma grading: an analysis of histologic parameters.

Authors:  A Perry; S L Stafford; B W Scheithauer; V J Suman; C M Lohse
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

6.  Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

Authors:  Manish K Aghi; Bob S Carter; Garth R Cosgrove; Robert G Ojemann; Sepideh Amin-Hanjani; Robert L Martuza; William T Curry; Fred G Barker
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

Review 7.  Radiotherapy for malignant tumors of the skull base.

Authors:  Julian Johnson; Igor J Barani
Journal:  Neurosurg Clin N Am       Date:  2013-01       Impact factor: 2.509

8.  The role of adjuvant radiotherapy in atypical meningioma.

Authors:  Hae Jin Park; Hyun-Cheol Kang; Il Han Kim; Sung-Hye Park; Dong Gyu Kim; Chul-Kee Park; Sun Ha Paek; Hee-Won Jung
Journal:  J Neurooncol       Date:  2013-08-15       Impact factor: 4.130

9.  Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews.

Authors:  Mehtap Coskun; William Straube; Coen W Hurkmans; Christos Melidis; Patricia F de Haan; Salvador Villà; Sandra Collette; Damien C Weber
Journal:  Radiat Oncol       Date:  2013-01-30       Impact factor: 3.481

Review 10.  Radiation Treatment for WHO Grade II and III Meningiomas.

Authors:  Brian P Walcott; Brian V Nahed; Priscilla K Brastianos; Jay S Loeffler
Journal:  Front Oncol       Date:  2013-09-02       Impact factor: 6.244

View more
  13 in total

1.  Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.

Authors:  Ammoren Dohm; Emory R McTyre; Michael D Chan; Claire Fan; Scott Isom; J Daniel Bourland; Ryan T Mott; Christina K Cramer; Stephen B Tatter; Adrian W Laxton
Journal:  J Clin Neurosci       Date:  2017-09-13       Impact factor: 1.961

2.  Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.

Authors:  Suresh K Balasubramanian; Mayur Sharma; Danilo Silva; Vidhya Karivedu; Philipp Schmitt; Glen H Stevens; Gene H Barnett; Richard A Prayson; Paul Elson; John H Suh; Erin S Murphy; Samuel T Chao
Journal:  J Neurooncol       Date:  2016-11-18       Impact factor: 4.130

3.  Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma.

Authors:  Daijun Wang; Shuchen Sun; Lingyang Hua; Jiaojiao Deng; Shihai Luan; Haixia Cheng; Qing Xie; Hiroaki Wakimoto; Hongda Zhu; Ye Gong
Journal:  Front Oncol       Date:  2020-11-10       Impact factor: 6.244

4.  Hypofractionated stereotactic radiotherapy (HFSRT) for who grade I anterior clinoid meningiomas (ACM).

Authors:  Selcuk Demiral; Ferrat Dincoglan; Omer Sager; Hakan Gamsiz; Bora Uysal; Esin Gundem; Yelda Elcim; Bahar Dirican; Murat Beyzadeoglu
Journal:  Jpn J Radiol       Date:  2016-09-22       Impact factor: 2.374

5.  Long-term outcomes of multimodality management for parasagittal meningiomas.

Authors:  Lingyang Hua; Daijun Wang; Hongda Zhu; Jiaojiao Deng; Shihai Luan; Haixia Chen; Shuchen Sun; Hailiang Tang; Qing Xie; Hiroaki Wakimoto; Ye Gong
Journal:  J Neurooncol       Date:  2020-02-22       Impact factor: 4.130

6.  Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base.

Authors:  Whitney A Sumner; Arya Amini; Todd C Hankinson; Nicholas K Foreman; Laurie E Gaspar; Brian D Kavanagh; Sana D Karam; Chad G Rusthoven; Arthur K Liu
Journal:  Rep Pract Oncol Radiother       Date:  2017-10-28

7.  Prognostic factors for patients with World Health Organization grade III meningiomas treated at a single center.

Authors:  Baoyin Shan; Jing Zhang; Yanlin Song; Jianguo Xu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 8.  Recent advances in managing/understanding meningioma.

Authors:  Nawal Shaikh; Karan Dixit; Jeffrey Raizer
Journal:  F1000Res       Date:  2018-04-24

9.  Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas.

Authors:  Barbara Zollner; Ute Ganswindt; Cornelius Maihöfer; Stefanie Corradini; Nathalie Lisa Albert; Christian Schichor; Claus Belka; Maximilian Niyazi
Journal:  Radiat Oncol       Date:  2018-06-14       Impact factor: 3.481

10.  Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.

Authors:  Hongda Zhu; Wenya Linda Bi; Ayal Aizer; Lingyang Hua; Mi Tian; Jiaojiao Den; Hailiang Tang; Hong Chen; Yin Wang; Ying Mao; Ian F Dunn; Qing Xie; Ye Gong
Journal:  Cancer Med       Date:  2019-01       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.